Health, Wealth, and the 21st Century Cures Act
Author(s)
Philipson, Tomas J.; von Eschenbach, Andrew C.; Lo, Andrew W
DownloadHealth-Wealth-and-21st-century.pdf (108.7Kb)
OPEN_ACCESS_POLICY
Open Access Policy
Creative Commons Attribution-Noncommercial-Share Alike
Terms of use
Metadata
Show full item recordAbstract
Americans are increasingly apprehensive about our future, so it is inspiring when Congress produces legislation intended to both enhance our health and expand our economy. The 21st Century Cures Act,1 recently passed by the House with an impressive bipartisan majority vote of 344 to 77, intends to accelerate the many-step process of drug discovery and development, from basic scientific research to clinical development to delivery, distribution, and ongoing monitoring. Among other things, the legislation boosts National Institute of Health funding, dramatically speeds up the US Food and Drug Administration (FDA) approval process, and aims to make use of new information technology to better monitor the performance of medical products after they reach the market. This landmark bill now awaits a comparable piece of legislation being developed by the Senate Health Education, Labor, and Pensions Committee. Together, they will transform the biomedical ecosystem and provide the foundation for the next several decades of innovative life-saving and health-enhancing solutions for our nation and the world.
Date issued
2015-10Department
Sloan School of ManagementJournal
JAMA Oncology
Citation
Lo, Andrew W.; Philipson, Tomas J. and von Eschenbach, Andrew C. “Health, Wealth, and the 21st Century Cures Act.” JAMA Oncology 2, no. 1 (January 2016): 17.
Version: Author's final manuscript
ISSN
2374-2437
2374-2445